Product Code: ETC340887 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The polio vaccine market in Singapore is essential for eradicating polio infections. Market trends are driven by public health campaigns, immunization efforts, and global initiatives to eliminate polio. Key players include vaccine manufacturers and healthcare organizations contributing to polio vaccination programs.
The Singapore polio vaccine market is expected to experience growth as it plays a crucial role in public health and disease prevention. Polio vaccines are essential for immunizing individuals against poliovirus infections. As healthcare systems prioritize vaccination programs and disease eradication efforts, the demand for polio vaccines in Singapore is likely to rise, driven by their critical role in achieving and maintaining polio-free status.
The Singapore polio vaccine market encounters challenges related to vaccine hesitancy and misinformation. To maintain polio eradication efforts, it is essential to address vaccine-related concerns and promote public awareness about the safety and efficacy of polio vaccines.
The COVID-19 pandemic had a moderate impact on the Singapore polio vaccine market. Polio vaccination programs continued, albeit with some disruptions due to lockdowns and restrictions. Vaccine distribution and administration strategies had to be adjusted to ensure that polio vaccinations were carried out safely and efficiently.
Pharmaceutical companies like Sanofi and GlaxoSmithKline are pivotal players in the Singapore polio vaccine market. Their vaccines are crucial for preventing polio and supporting public health initiatives.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Polio Vaccine Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Polio Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Polio Vaccine Market - Industry Life Cycle |
3.4 Singapore Polio Vaccine Market - Porter's Five Forces |
3.5 Singapore Polio Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Singapore Polio Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Singapore Polio Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and emphasis on public health and immunization programs in Singapore |
4.2.2 Government initiatives and policies promoting vaccination against polio |
4.2.3 Growing healthcare infrastructure and access to vaccination services in the region |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy and misinformation leading to a decrease in vaccination rates |
4.3.2 High cost associated with vaccine production and distribution |
4.3.3 Regulatory challenges and stringent approval processes for new vaccines |
5 Singapore Polio Vaccine Market Trends |
6 Singapore Polio Vaccine Market, By Types |
6.1 Singapore Polio Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Singapore Polio Vaccine Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Singapore Polio Vaccine Market Revenues & Volume, By Oral Polio Vaccine (OPV), 2021-2031F |
6.1.4 Singapore Polio Vaccine Market Revenues & Volume, By Inactivated Poliomyelitis Vaccine (IPV), 2021-2031F |
6.2 Singapore Polio Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Singapore Polio Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.2.3 Singapore Polio Vaccine Market Revenues & Volume, By Private, 2021-2031F |
7 Singapore Polio Vaccine Market Import-Export Trade Statistics |
7.1 Singapore Polio Vaccine Market Export to Major Countries |
7.2 Singapore Polio Vaccine Market Imports from Major Countries |
8 Singapore Polio Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rate among children in Singapore |
8.2 Number of reported polio cases in the region |
8.3 Percentage of healthcare facilities offering polio vaccination services |
8.4 Research and development investment in new polio vaccine technologies |
8.5 Public perception and trust in polio vaccination efficacy |
9 Singapore Polio Vaccine Market - Opportunity Assessment |
9.1 Singapore Polio Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Singapore Polio Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Singapore Polio Vaccine Market - Competitive Landscape |
10.1 Singapore Polio Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Singapore Polio Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |